[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100276448":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":13,"centralContacts":18,"locations":24,"responsibleParty":55,"collaborators":58,"id":72,"slug":10,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":10,"eligibilityCriteria":77,"healthyVolunteers":73,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":84,"studyType":85,"phases":10,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"University Hospital, Gasthuisberg","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Study group",null,{"label":12,"type":10,"description":10,"interventionNames":10},"control group",[14],{"name":15,"affiliation":16,"role":17},"Frédéric Amant, MD, PhD","UZ Gasthuisberg & KU Leuven, Belgium","PRINCIPAL_INVESTIGATOR",[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Katrien Van Tornout","CONTACT","+3216342876","katrien.vantornout@uzleuven.be",[25,40],{"facility":26,"status":27,"city":28,"state":10,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"UZ Gasthuisberg, Katholieke Universiteit Leuven","RECRUITING","Leuven","3000","Belgium",{"type":32,"coordinates":33},"Point",[34,35],4.70093,50.87959,{"lat":35,"lon":34},[38,39],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"name":15,"role":17,"phone":10,"phoneExt":10,"email":10},{"facility":41,"status":27,"city":42,"state":10,"zip":10,"country":43,"cosmosGeoPoint":44,"geoPoint":48,"contacts":49},"The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital","Amsterdam","Netherlands",{"type":32,"coordinates":45},[46,47],4.88969,52.37403,{"lat":47,"lon":46},[50,53],{"name":51,"role":21,"phone":10,"phoneExt":10,"email":52},"Christianne Lok, MD, PhD","c.lok@nki.nl",{"name":51,"role":54,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"type":17,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Frederic Amant","MD PhD",[59,62,64,66,68,70],{"name":60,"class":61},"NKI-AvL","UNKNOWN",{"name":63,"class":6},"Medical University of Vienna",{"name":65,"class":6},"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",{"name":67,"class":6},"Oslo University Hospital",{"name":69,"class":6},"Haukeland University Hospital",{"name":71,"class":61},"N.N. Blokchin NMRCO","100276448",false,"NCT02878434","Fertility Preservation in Young Women With Cancer","Fertility Preservation in Young Women With Cancer: an International Registration Study From the International Network on Cancer, Infertility and Pregnancy (INCIP)","Inclusion Criteria:\n\n* Young women who want to preserve their fertility during cancer treatment. Patients need to give their signed and written informed consent to participate in the study.\n\nExclusion Criteria:\n\n* Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent","FEMALE","0 Years","40 Years",{"count":82,"type":83},2000,"ESTIMATED","5 Years","OBSERVATIONAL","The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded.\n\nStudy population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared to young women undergoing standard cancer treatment.",[88,89],"Cancer","Fertility",[88,89,91,92,93,94,95],"Pregnancy","Chemotherapy","Radiotherapy","Long term","Follow up","2020-11-17",{"date":98,"type":99},"2020-11-18","ACTUAL",{"date":101,"type":99},"2017-05-23",{"date":103,"type":83},"2032-07",{"name":5,"class":6},2]